Current Investment Opportunities

All our investments have a lead investor who invests at the same share price, and receives the same share class as you. We don't charge a membership fee, nor do we take a percentage of any profits. There is also EIS and SEIS tax relief available on most opportunities.


 

15 DAYS TO GO
EIS
Adoreboard’s proprietary software allows companies to turn customer emotions into actionable insights. Lead investor, Michael Black, MBE, is currently serving as Chairman and Non-Executive Director for a number of companies, including Adoreboard.
N E W
Web & Apps
Lead Investor
CAPITAL INVESTED
£261,286
 
  123%
EQUITY OFFERED
29.26%
CAPITAL REQUIRED
£212,142
PRE-MONEY VALUATION
£512,952
 
Image Scan
3DX-RAY Ltd is a global market and technology leader in line-scan x-ray imaging systems for the security and industrial inspection markets.
Hardware
Lead Investor
CAPITAL INVESTED
£1
 
  0%
EQUITY OFFERED
10.00%
CAPITAL REQUIRED
£1,000,000
PRE-MONEY VALUATION
£9,000,000
 
26 HOURS TO GO
EIS
Absynth Biologics aims to discover and develop vaccines to prevent and treat common bacterial infections. This round is lead by Alderley Park Ventures (APV), a £5M incubation fund managed by the BioCity Group.
Health | B2B – Business to Business
Lead Investor
CAPITAL INVESTED
£260,702
 
  65%
EQUITY OFFERED
10.94%
CAPITAL REQUIRED
£400,000
PRE-MONEY VALUATION
£3,255,700
 
8 DAYS TO GO
EIS
Popsa uses artificial intelligence to cut the time and effort that is required to design and order personalised products and gifts. Lead investor, Zeev Remez, co-founded communication businesses E.C. Datacom Limited and E.C. Datacom Clearing Limited.
B2C – Business to Consumer
Lead Investor
CAPITAL INVESTED
£364,000
 
  73%
EQUITY OFFERED
10.75%
CAPITAL REQUIRED
£500,000
PRE-MONEY VALUATION
£4,150,000
 
OVERFUNDING 8 DAYS TO GO
EIS
Active Needle Technology has developed technology to help doctors perform needle based procedures with greater accuracy and reliability. Oxford Technology, an award-winning fund, specialising in start-up and early stage technology, is leading the round.
Lead Investor
CAPITAL INVESTED
£274,849
 
  110%
EQUITY OFFERED
16.58%
CAPITAL REQUIRED
£250,000
PRE-MONEY VALUATION
£1,258,124
 
33 DAYS TO GO
EIS
Fund Twenty8™ is the first passive investment fund for early stage investing. It is designed to deliver multi-sector exposure and generate a large portfolio of at least 28 or more investments.
B2C – Business to Consumer
Lead Investor
CAPITAL INVESTED
£280,000
 
  0%
EQUITY OFFERED
0.00%
CAPITAL REQUIRED
£0
PRE-MONEY VALUATION
£0